← 返回

肺癌通过转录因子核定位诱导 NK 细胞收缩性和细胞毒性

英文原题:Lung Cancer Induces NK Cell Contractility and Cytotoxicity Through Transcription Factor Nuclear Localization.

查看英文原题

Lung Cancer Induces NK Cell Contractility and Cytotoxicity Through Transcription Factor Nuclear Localization.

PubMed 2022/05/16(内容时间) Front Cell Dev Biol Q1 · IF 5.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肌动蛋白-肌球蛋白介导的细胞收缩性在机械转导和信号传导中高度保守。虽然这一现象已在贴壁细胞模型中被观察到,但收缩力是否/如何调控自然杀伤(NK)细胞等悬浮细胞在肿瘤监视过程中的功能,尚不清楚。

在此,我们在共培养体系中证明,进化上保守的NK细胞转录因子Eomes在肺癌细胞监视过程中发生核穿梭。生物物理和生化分析揭示了NK细胞肌动蛋白-肌球蛋白介导的收缩性在机制上的增强,这与核变平相关,从而使Eomes能够入核,并与NK细胞毒性增强相关。

我们发现,NK细胞对NK-肺癌共培养介质中推测具有免疫抑制作用的TGFβ作出响应,通过肌球蛋白轻链磷酸化维持其细胞内收缩性,从而促进Eomes核定位。

因此,我们的结果表明,肺癌细胞激发NK细胞收缩性作为一种早期阶段激活机制,而Eomes是NK细胞毒性增强的一个可能的机械响应蛋白。在体内过继性肿瘤免疫治疗之前,于体外策略性应用肌动蛋白-肌球蛋白介导的收缩性调节药物以重振NK细胞,具有应用空间(177词)。

展开英文摘要原文

Actomyosin-mediated cellular contractility is highly conserved for mechanotransduction and signalling. While this phenomenon has been observed in adherent cell models, whether/how contractile forces regulate the function of suspension cells like natural killer (NK) cells during cancer surveillance, is unknown.

Here, we demonstrated in coculture settings that the evolutionarily conserved NK cell transcription factor, Eomes, undergoes nuclear shuttling during lung cancer cell surveillance. Biophysical and biochemical analyses revealed mechanistic enhancement of NK cell actomyosin-mediated contractility, which is associated with nuclear flattening, thus enabling nuclear entry of Eomes associated with enhanced NK cytotoxicity.

We found that NK cells responded to the presumed immunosuppressive TGFβ in the NK-lung cancer coculture medium to sustain its intracellular contractility through myosin light chain phosphorylation, thereby promoting Eomes nuclear localization.

Therefore, our results demonstrate that lung cancer cells provoke NK cell contractility as an early phase activation mechanism and that Eomes is a plausible mechano-responsive protein for increased NK cytotoxicity. There is scope for strategic application of actomyosin-mediated contractility modulating drugs ex vivo, to reinvigorate NK cells prior to adoptive cancer immunotherapy in vivo (177 words).

论文信息

作者
Wong DCP、Lee EHC、Er J、Yow I、Koean RAG、Ang O、Xiao J、Low BC
单位
Department of Biological Sciences, National University of Singapore, Singapore, Singapore.Singapore
期刊
Frontiers in cell and developmental biology2022
原文标识
PubMed 35652099 · DOI 10.3389/fcell.2022.871326